Difference between revisions of "Woessner 2020 Thesis"
m (Plangger Mario moved page Woessner 2020 Nutrients to Woessner 2020 Thesis over a redirect without leaving a redirect) |
|||
Line 1: | Line 1: | ||
{{Publication | {{Publication | ||
|title=Mary N. Woessner (2020) BEET-HF: the effects of dietary inorganic nitrate supplementation on aerobic exercise performance, vascular function, cardiac performance and mitochondrial respiration in patients with heart failure with reduced ejection fraction. PhD Thesis 198. | |title=Mary N. Woessner (2020) BEET-HF: the effects of dietary inorganic nitrate supplementation on aerobic exercise performance, vascular function, cardiac performance and mitochondrial respiration in patients with heart failure with reduced ejection fraction. PhD Thesis 198. | ||
|info=[https:// | |info=[https://vuir.vu.edu.au/40041/ Open Access] | ||
|authors=Woessner Mary N | |authors=Woessner Mary N | ||
|year=2020 | |year=2020 | ||
|journal=PhD Thesis | |journal=PhD Thesis | ||
|abstract= | |abstract=Chronic heart failure (CHF) is characterised by an inability of the heart to pump enough | ||
blood to meet the body’s metabolic needs, resulting in exercise intolerance. A reduction | |||
in nitric oxide (NO) bioavailability has been implicated as an initiator and/or contributor | |||
to many of the peripheral skeletal tissue dysfunctions that contribute to the exercise | |||
intolerance in patients with CHF. Inorganic nitrate supplementation has been identified | |||
as an important mediator of exercise tolerance via increasing NO bioavailability, but the | |||
potential efficacy of this on patients with heart failure with reduced ejection fraction | |||
(HFrEF) as well as the effect on vascular function is not well understood and was the | |||
focus of Study 1. Additionally, to our knowledge, no previous study has examined the | |||
potential impact of nitrate supplementation on cardiac performance during submaximal | |||
exercise and mitochondrial respiration in individuals with HFrEF. These were the foci | |||
of Studies 2 and 3 respectively. | |||
|editor=[[Reiswig R]] | |||
}} | |||
{{Labeling | |||
|area=Respiration, Exercise physiology;nutrition;life style, Pharmacology;toxicology | |||
|diseases=Cardiovascular | |||
|organism=Human | |||
|tissues=Skeletal muscle | |||
|preparations=Permeabilized tissue | |||
|enzymes=Complex I | |||
|couplingstates=LEAK, OXPHOS, ET | |||
|pathways=N, S, NS, ROX | |||
|instruments=Oxygraph-2k | |||
|additional=2021-07 | |||
}} | }} | ||
Revision as of 13:38, 14 July 2021
Mary N. Woessner (2020) BEET-HF: the effects of dietary inorganic nitrate supplementation on aerobic exercise performance, vascular function, cardiac performance and mitochondrial respiration in patients with heart failure with reduced ejection fraction. PhD Thesis 198. |
Woessner Mary N (2020) PhD Thesis
Abstract: Chronic heart failure (CHF) is characterised by an inability of the heart to pump enough blood to meet the body’s metabolic needs, resulting in exercise intolerance. A reduction in nitric oxide (NO) bioavailability has been implicated as an initiator and/or contributor to many of the peripheral skeletal tissue dysfunctions that contribute to the exercise intolerance in patients with CHF. Inorganic nitrate supplementation has been identified as an important mediator of exercise tolerance via increasing NO bioavailability, but the potential efficacy of this on patients with heart failure with reduced ejection fraction (HFrEF) as well as the effect on vascular function is not well understood and was the focus of Study 1. Additionally, to our knowledge, no previous study has examined the potential impact of nitrate supplementation on cardiac performance during submaximal exercise and mitochondrial respiration in individuals with HFrEF. These were the foci of Studies 2 and 3 respectively.
• Bioblast editor: Reiswig R
Labels: MiParea: Respiration, Exercise physiology;nutrition;life style, Pharmacology;toxicology
Pathology: Cardiovascular
Organism: Human Tissue;cell: Skeletal muscle Preparation: Permeabilized tissue Enzyme: Complex I
Coupling state: LEAK, OXPHOS, ET Pathway: N, S, NS, ROX HRR: Oxygraph-2k
2021-07